Shares of Recursion Pharmaceuticals (NASDAQ: RXRX) fell this week. The stock lost 24% as of market close on Friday. The move ...

Shares of Recursion Pharmaceuticals ( RXRX -11.15%) are tumbling on Tuesday. The stock lost 10.3% as of 2:50 p.m. ET and was ...

We talk about news in cancer, updates on COVID's origin, and business news in biotech in this episode of Touching Base.

AI business Recursion Pharmaceuticals has narrowed its drug development pipeline, ending or pausing five programmes as it ...

Recursion has agreed to buy Exscientia, and the company aims to use new techniques for discovering drug compounds, including deep learning. Perhaps the most direct application of AI in healthcare ...

Each function in this library is tested thoroughly and is not deoptimized by v8 (except some logging and comparison functions that can't be implemented without deoptimizations). This library ...